$AMRI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALBANY MOLECULAR RESEARCH INC. Get notifications about new insider transactions in ALBANY MOLECULAR RESEARCH INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2008 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 9.19 | 1,666 | 15,311 | 3,333 | |
Nov 21 2008 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 9.19 | 1,667 | 15,320 | 1,667 | |
Nov 19 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 9.72 | 2,711 | 26,351 | 25,289 | 28 K to 25.3 K (-9.68 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 13.16 | 100 | 1,316 | 4,619,428 | 4.6 M to 4.6 M (0.00 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 13.15 | 1,718 | 22,592 | 4,619,528 | 4.6 M to 4.6 M (-0.04 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 13.09 | 118 | 1,545 | 4,621,246 | 4.6 M to 4.6 M (0.00 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Sell | S | 13.04 | 64 | 835 | 4,621,364 | 4.6 M to 4.6 M (0.00 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Sell | S | 13.16 | 100 | 1,316 | 4,619,428 | 4.6 M to 4.6 M (0.00 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Sell | S | 13.15 | 1,718 | 22,592 | 4,619,528 | 4.6 M to 4.6 M (-0.04 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Sell | S | 13.09 | 118 | 1,545 | 4,621,246 | 4.6 M to 4.6 M (0.00 %) |
Nov 07 2008 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Sell | S | 13.04 | 64 | 835 | 4,621,364 | 4.6 M to 4.6 M (0.00 %) |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 13.20 | 3,000 | 39,600 | 15,000 | |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 13.20 | 3,000 | 39,600 | 12,000 | |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 13.20 | 9,000 | 118,800 | 9,000 | |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Grant | A | 13.20 | 5,000 | 66,000 | 28,000 | 23 K to 28 K (+21.74 %) |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Jun 06 2008 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Grant | A | 13.95 | 1,075 | 14,996 | 6,294 | 5.2 K to 6.3 K (+20.60 %) |
Jun 06 2008 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Grant | A | 13.95 | 1,075 | 14,996 | 5,880 | 4.8 K to 5.9 K (+22.37 %) |
Jun 06 2008 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Grant | A | 13.95 | 1,075 | 14,996 | 120,258 | 119.2 K to 120.3 K (+0.90 %) |
Jun 06 2008 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 13.95 | 1,000 | 13,950 | 16,000 | 15 K to 16 K (+6.67 %) |
Jun 06 2008 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 13.95 | 2,150 | 29,993 | 6,758 | 4.6 K to 6.8 K (+46.66 %) |
Jun 06 2008 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Grant | A | 13.95 | 2,150 | 29,993 | 34,561 | 32.4 K to 34.6 K (+6.63 %) |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.21 | 2,400 | 26,904 | 12,000 | |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.21 | 2,400 | 26,904 | 9,600 | |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 11.21 | 7,200 | 80,712 | 7,200 | |
Mar 18 2008 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 11.21 | 4,000 | 44,840 | 31,600 | 27.6 K to 31.6 K (+14.49 %) |
Feb 19 2008 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Buy | P | 10.53 | 1,000 | 10,530 | 15,000 | 14 K to 15 K (+7.14 %) |
Nov 21 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.81 | 710 | 9,095 | 10,321 | 9.6 K to 10.3 K (+7.39 %) |
Nov 21 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.79 | 483 | 6,178 | 9,611 | 9.1 K to 9.6 K (+5.29 %) |
Nov 21 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.58 | 1,025 | 12,895 | 9,128 | 8.1 K to 9.1 K (+12.65 %) |
Dec 05 2007 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Buy | P | 12.67 | 2,000 | 25,340 | 14,000 | 12 K to 14 K (+16.67 %) |
Nov 20 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Buy | P | 12.00 | 2,500 | 30,000 | 4,805 | 2.3 K to 4.8 K (+108.46 %) |
Nov 09 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 12.18 | 2,500 | 30,450 | 27,600 | 25.1 K to 27.6 K (+9.96 %) |
Oct 03 2007 | AMRI | ALBANY MOLECULAR R ... | Evans Johnathan D | VP Pharma Dev & Man ... | Option Exercise | A | 15.99 | 6,000 | 95,940 | 30,000 | |
Oct 03 2007 | AMRI | ALBANY MOLECULAR R ... | Evans Johnathan D | VP Pharma Dev & Man ... | Option Exercise | A | 15.99 | 6,000 | 95,940 | 24,000 | |
Oct 03 2007 | AMRI | ALBANY MOLECULAR R ... | Evans Johnathan D | VP Pharma Dev & Man ... | Option Exercise | A | 15.99 | 18,000 | 287,820 | 18,000 | |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | M | 4.44 | 3,750 | 16,650 | 0 | |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | M | 4.44 | 3,750 | 16,650 | 3,750 | |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | M | 4.44 | 3,750 | 16,650 | 7,500 | |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Sell | S | 15.35 | 71 | 1,090 | 32,411 | 32.5 K to 32.4 K (-0.22 %) |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Sell | S | 15.31 | 700 | 10,717 | 32,482 | 33.2 K to 32.5 K (-2.11 %) |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Sell | S | 15.30 | 2,485 | 38,021 | 33,182 | 35.7 K to 33.2 K (-6.97 %) |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Sell | S | 15.32 | 514 | 7,874 | 35,667 | 36.2 K to 35.7 K (-1.42 %) |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Sell | S | 15.45 | 7,480 | 115,566 | 36,181 | 43.7 K to 36.2 K (-17.13 %) |
Sep 07 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Buy | M | 4.44 | 11,250 | 49,950 | 43,661 | 32.4 K to 43.7 K (+34.71 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 14.47 | 1,037 | 15,005 | 8,103 | 7.1 K to 8.1 K (+14.68 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Grant | A | 14.47 | 1,037 | 15,005 | 2,305 | 1.3 K to 2.3 K (+81.78 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 14.47 | 2,073 | 29,996 | 4,608 | 2.5 K to 4.6 K (+81.78 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Grant | A | 14.47 | 1,037 | 15,005 | 127,183 | 126.1 K to 127.2 K (+0.82 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Grant | A | 14.47 | 2,073 | 29,996 | 32,411 | 30.3 K to 32.4 K (+6.83 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Grant | A | 14.47 | 1,037 | 15,005 | 5,219 | 4.2 K to 5.2 K (+24.80 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 14.47 | 1,000 | 14,470 | 12,000 | 11 K to 12 K (+9.09 %) |
Mar 26 2007 | AMRI | ALBANY MOLECULAR R ... | Evans Johnathan D | VP Pharma Dev & Man ... | Grant | A | 10.02 | 20,000 | 200,400 | 20,000 | 0 to 20 K |
Mar 16 2007 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Gift | G | 9.50 | 23,022 | 218,709 | 4,647,416 | 4.7 M to 4.6 M (-0.49 %) |
Mar 16 2007 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Gift | G | 9.50 | 23,022 | 218,709 | 4,647,416 | 4.7 M to 4.6 M (-0.49 %) |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 9.34 | 2,400 | 22,416 | 56,700 | |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 9.34 | 2,400 | 22,416 | 54,300 | |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 9.34 | 7,200 | 67,248 | 51,900 | |
Mar 06 2007 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 9.34 | 4,000 | 37,360 | 25,100 | 21.1 K to 25.1 K (+18.96 %) |
Jan 09 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 11.83 | 1,666 | 19,709 | 5,000 | |
Jan 09 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 11.83 | 1,667 | 19,721 | 3,333 | |
Jan 09 2007 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 11.83 | 1,666 | 19,709 | 1,666 | |
Jan 09 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 11.83 | 1,667 | 19,721 | 5,000 | |
Jan 09 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 11.83 | 1,666 | 19,709 | 3,333 | |
Jan 09 2007 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 11.83 | 1,667 | 19,721 | 1,667 | |
Dec 22 2006 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Buy | P | 11.83 | 1,268 | 15,000 | 1,268 | 0 to 1.3 K |
Dec 22 2006 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Gift | G | 11.19 | 75,000 | 839,250 | 4,670,438 | 4.7 M to 4.7 M (-1.58 %) |
Dec 22 2006 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Gift | G | 11.19 | 75,000 | 839,250 | 4,670,438 | 4.7 M to 4.7 M (-1.58 %) |
Dec 21 2006 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Gift | G | 10.56 | 16,600 | 175,296 | 4,745,438 | 4.8 M to 4.7 M (-0.35 %) |
Dec 21 2006 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Gift | G | 10.56 | 16,600 | 175,296 | 4,745,438 | 4.8 M to 4.7 M (-0.35 %) |
Nov 01 2006 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 11.83 | 2,535 | 29,989 | 2,535 | 0 to 2.5 K |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | HAYDU FRANK | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | HAYDU FRANK | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | HAYDU FRANK | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Buy | P | 10.45 | 2,500 | 26,125 | 21,100 | 18.6 K to 21.1 K (+13.44 %) |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | TROVA MICHAEL P | Sr. VP, Chemistry | Option Exercise | A | 10.03 | 1,200 | 12,036 | 84,923 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | TROVA MICHAEL P | Sr. VP, Chemistry | Option Exercise | A | 10.03 | 1,200 | 12,036 | 83,723 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | TROVA MICHAEL P | Sr. VP, Chemistry | Option Exercise | A | 10.03 | 3,600 | 36,108 | 82,523 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | TROVA MICHAEL P | Sr. VP, Chemistry | Grant | A | 10.03 | 3,000 | 30,090 | 65,488 | 62.5 K to 65.5 K (+4.80 %) |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Shultis Kenton L | VP and GM, Organich ... | Option Exercise | A | 10.03 | 1,200 | 12,036 | 32,575 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Shultis Kenton L | VP and GM, Organich ... | Option Exercise | A | 10.03 | 1,200 | 12,036 | 31,375 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Shultis Kenton L | VP and GM, Organich ... | Option Exercise | A | 10.03 | 3,600 | 36,108 | 30,175 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Shultis Kenton L | VP and GM, Organich ... | Grant | A | 10.03 | 3,000 | 30,090 | 45,523 | 42.5 K to 45.5 K (+7.06 %) |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 10.03 | 1,440 | 14,443 | 44,700 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 10.03 | 1,440 | 14,443 | 43,260 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Option Exercise | A | 10.03 | 4,320 | 43,330 | 41,820 | |
Jun 13 2006 | AMRI | ALBANY MOLECULAR R ... | Frost Mark T | Chief Financial Off ... | Grant | A | 10.03 | 3,600 | 36,108 | 18,600 | 15 K to 18.6 K (+24.00 %) |
Jun 02 2006 | AMRI | ALBANY MOLECULAR R ... | ANDERSON PAUL S | Director | Grant | A | 10.37 | 1,446 | 14,995 | 4,182 | 2.7 K to 4.2 K (+52.85 %) |
Jun 02 2006 | AMRI | ALBANY MOLECULAR R ... | KUHLA DONALD E | Executive Vice Pres ... | Grant | A | 10.37 | 964 | 9,997 | 125,664 | 124.7 K to 125.7 K (+0.77 %) |
Jun 02 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 10.37 | 964 | 9,997 | 6,584 | 5.6 K to 6.6 K (+17.15 %) |
Jun 02 2006 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 10.37 | 1,000 | 10,370 | 11,000 | 10 K to 11 K (+10.00 %) |
Jun 02 2006 | AMRI | ALBANY MOLECULAR R ... | TARTAGLIA ANTHONY P | Director | Grant | A | 10.27 | 1,929 | 19,811 | 29,374 | 27.4 K to 29.4 K (+7.03 %) |
Dec 22 2005 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, CEO & Pre ... | Gift | G | 12.57 | 85,000 | 1,068,450 | 4,762,038 | 4.8 M to 4.8 M (-1.75 %) |
Dec 22 2005 | AMRI | ALBANY MOLECULAR R ... | D AMBRA CONSTANCE M | 10% Owner | Gift | G | 12.57 | 85,000 | 1,068,450 | 4,762,038 | 4.8 M to 4.8 M (-1.75 %) |